It allows the clinic to capture the patient early in their weight-loss journey, treat the immediate symptom (laxity), and retain them within the practice ecosystem until they are potentially ready for surgery or further maintenance
Nov 2023 - The FDA's approval of Eli Lillys Zepbound (tirzepatide) represents a significant advancement in obesity treatment, as it uniquely targets both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors
10.3390/antiox13101246 50 MaH.HuangW.WangX.ZhaoL.JiangY.LiuF.et al (2020)
To that end, Pendulum claims to use an acid-resistant capsule
Additional cautions include active or history of pancreatitis, severe gastroparesis, and severe GI dysmotility
If you have kidney disease, consult your healthcare provider about appropriate protein intake